Tumor Cells in Blood Shed From the Surgical Field

Archives of Surgery

Volumn 130, Issue 4, 1995, Pages 387-393

  Hansen, Ernil ^a   Wolff, Norbert ^a   Knuechel, Ruth ^a   Ruschoff, Josef ^a   Hofstaedter, Ferdinand ^a   Taeger, Kai ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; CANCER RISK; CANCER SURGERY; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; TUMOR CELL; TUMOR RECURRENCE;

BLOOD LOSS, SURGICAL; CELL COUNT; HUMAN; INTRAOPERATIVE PERIOD; NEOPLASM SEEDING; NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0028921925     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1995.01430040049007     Document Type: Article

References (27)

1. Turnbull RB, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg. 1967;166:420-427.
2. Nogueras JJ, Jagelman DG. Principles of surgical resection. Surg Clin North Am. 1993;73:103-116.
3. Wiggers T, Jeekel J, Arends JW, et al. No-touch isolation technique in colon cancer: a controlled prospective trial. Br J Surg. 1988;75:409-415.
4. Abcarian H. Operative treatment of colorectal cancer. Cancer. 1992;70(suppl 5):1350-1354.
5. Popovsky MA, Devine PA, Taswell HF. Intraoperative autologous transfusion. Mayo Clin Proc. 1985;60:125-134.
6. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet. 1993;342:1328-1333.
7. Francis DMA. Relationship between blood transfusion and tumor behavior. Br J Surg. 1991;78:1420-1428.
8. Yaw PB, Sentany M, Link WJ, Wahle WM, Glover JL. Tumor cells carried through autotransfusion: contraindication to intraoperative blood recovery? JAMA. 1975; 231:490-491.
9. Schlimok G, Funke I, Bock B, Schweiberer B, Witte J, Riethmüller G. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotype characterization, and prognostic significance. J Clin Oncol. 1990;8:831-837.
10. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood. 1994;83:636-640.
11. Mattano LA, Moss TJ, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by a reverse transcriptase chain reaction. Cancer Res. 1992; 52:4701-4705.
12. Ruschoff J, Neumann K, Contractor H, Plate K, Thomas C. Assessment of nucleolar organizer regions by automatic image analysis in breast cancer: correlation with DNA content, proliferation rate, receptor status and histopathological grading. J Cancer Res Clin Oncol. 1990;116:480-485.
13. Crocker J. Nucleolar organiser regions. Curr Top Pathol. 1990;82:91-149.
14. Glaves D. Methods for the purification of malignant cells from blood. In: Pretlow TG, Pretlow TP, eds. Cell Separation: Methods and Selected Applications. Orlando, Fla: Academic Press Inc; 1987:331-352.
15. Kurnick JT, Oestberg L, Stegagno M. A rapid method for the separation of functional lymphoid cell populations of human and animal origin on PVP-silica (Percoll) density gradients. Scand J Immunol. 1979;10:563-573.
16. Hamburger AW, Dunn FE, White CP. Percoll density gradient separation of cells from human malignant effusions. Br J Cancer. 1985;51:253-258.
17. Viac J, Reano A, Brochier J, Stawuet MJ, Thivolet J. Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol. 1983;81:351-354.
18. Knuechel R, Keng P, Hofstaedter F, Langmuir V, Sutherland RM, Penney DP. Differentiation patterns in two- and three-dimensional culture systems of human squamous carcinoma cell lines. Am J Pathol. 1990;137:725-736.
19. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ. Improvement in the staining and in the visualization of the argyrophylic proteins of the nucleolar organizer region at the optical level. Histochem J. 1986;18:5-14.
20. Knuechel R, Hotstadter F, Jenkins WEA, Masters JRW. Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy. Cancer Res. 1989;49:1397-1401.
21. Terranova VP, Hujanen E, Loeb DM, Martin GR, Thornburg L, Glushko V. Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. Proc Natl Acad Sci U S A. 1986;83:465-469.
22. Spruss T, Schlemmer R, Bernhardt G, Wiesenmeyer F, Baumann O. Five-year breeding data, immunology, and tumor take rates of an NMRI nude mouse colony. Contrib Oncol. In press.
23. Salsbury AJ. The significance of circulating cancer cell. Cancer Treat Rev. 1975; 2:55-72.
24. del Castillo CF, Warshaw AL. Peritoneal metastases in pancreatic carcinoma. Hepatogastroenterology. 1993;40:430-432.
25. Hart OJ, Klimberg IW, Wajsman Z, Baker J. Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder. Surg Gynecol Obstet. 1989; 168:302-306.
26. Fidler IJ. Cancer metastasis. Br Med Bull. 1991;47:157-177.
27. Hansen E, Frey I, Knuechel R, Ruschoff J, Taeger K. Tumor cells in intraoperatively salvaged blood and their elimination by leucocyte filters or γ-irradiation. Anesthesiology. 1993;79(suppl 3A):A122.